Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenue:
Total revenue		$ 45,917	$ 27,643	$ 362,497	$ 230,384
Operating expenses:
Royalty fees		5,210	3,610	49,847	23,622
Research and development	[1]	26,685	15,046	53,052	27,403
Sales and marketing	[1]	3,120	1,295	5,490	3,869
General and administrative	[1]	14,412	11,203	28,680	17,688
Depreciation and amortization		4,886	3,522	8,875	6,827
Total operating expenses		54,313	34,676	145,944	79,409
Income (loss) from operations		(8,396)	(7,033)	216,553	150,975
Other (income) expense
Other (income) expense		25	(314)	(641)	(645)
Grants and incentives		(1,535)	(4,646)	(6,730)	(7,794)
Total other (income)		(1,510)	(4,960)	(7,371)	(8,439)
Net earnings (loss) before income tax		(6,886)	(2,073)	223,924	159,414
Income tax (recovery) expense		(101)	250	62,136	44,516
Net earnings (loss)		(6,785)	(2,323)	161,788	114,898
Foreign currency translation adjustment		(211)	2,152	296	2,152
Comprehensive income (loss)		$ (6,996)	$ (171)	$ 162,084	$ 117,050
Net earnings (loss) per share attributable to common shareholders
Basic		$ (0.02)	$ (0.01)	$ 0.57	$ 0.42
Diluted		$ (0.02)	$ (0.01)	$ 0.52	$ 0.36
Weighted-average common shares outstanding
Basic		284,686,542	272,196,107	284,292,312	270,953,541
Diluted		284,686,542	272,196,107	313,361,183	321,555,443
Research Fees
Revenue:
Total revenue		$ 12,538	$ 5,215	$ 21,871	$ 9,201
Licensing Revenue
Revenue:
Total revenue		147	263	377	20,522
Milestone Payments
Revenue:
Total revenue			1,000		8,000
Royalty Revenue
Revenue:
Total revenue		$ 33,232	$ 21,165	$ 340,249	$ 192,661

[1] Exclusive of depreciation and amortization